Use of Vaxfectin adjuvant with DNA vaccine encoding the measles virus hemagglutinin and fusion proteins protects juvenile and infant rhesus macaques against measles virus
about
Vaccines: the Fourth CenturyMitigating the looming vaccine crisis: production and delivery of plasmid-based vaccinesComparison of the immune responses induced by chimeric alphavirus-vectored and formalin-inactivated alum-precipitated measles vaccines in miceProspects for control of emerging infectious diseases with plasmid DNA vaccines.A chimeric alphavirus replicon particle vaccine expressing the hemagglutinin and fusion proteins protects juvenile and infant rhesus macaques from measlesTechnologies for enhanced efficacy of DNA vaccines.Poor immune responses of newborn rhesus macaques to measles virus DNA vaccines expressing the hemagglutinin and fusion glycoproteins.Generation of a More Immunogenic Measles Vaccine by Increasing Its Hemagglutinin Expression.Vaxfectin-adjuvanted plasmid DNA vaccine improves protection and immunogenicity in a murine model of genital herpes infectionThe successful induction of T-cell and antibody responses by a recombinant measles virus-vectored tetravalent dengue vaccine provides partial protection against dengue-2 infection.Measles vaccination: new strategies and formulations.Vaxfectin: a versatile adjuvant for plasmid DNA- and protein-based vaccines.Cationic liposomal vaccine adjuvants in animal challenge models: overview and current clinical status.Vaxfectin adjuvant improves antibody responses of juvenile rhesus macaques to a DNA vaccine encoding the measles virus hemagglutinin and fusion proteins.DNA vaccines encoding proteins from wild-type and attenuated canine distemper virus protect equally well against wild-type virus challenge.Measles Vaccine.
P2860
Q27490454-96848F49-9471-4A27-8992-E117403CBEBBQ28294355-11AB0301-7AFA-4C45-A5BB-5D81C08EF5CAQ28752489-B2E61961-A10E-4BE8-9A34-D77442E5AF7CQ30380454-E47058C6-07CA-46B9-B1E9-E70BC5A4EDEAQ33769306-D58F7850-CE1D-47F9-BA6D-6F37177A87CCQ35802958-84846463-FA1E-4CAD-8580-F5682A145452Q36606717-A061C072-5C69-4C61-B7B6-9ECB718A62E4Q37069798-10ECBE82-7E05-4CA9-AB78-5AE42442BFC1Q37127506-5E1E37DE-13A0-4E64-84F1-4D52DA941100Q37135489-1D2E268D-8EAE-4EF6-8A1E-6D553343D5C3Q37290110-6CD270BC-4BF7-4F36-8786-80241FE2F7F6Q37813689-C5A6A8C9-5B49-40FC-9B46-67C4FD8C217EQ38028994-A87205D0-9D3A-46E1-88CA-0BE8D3F769BBQ42079721-2457880E-C933-4296-85CB-E539CC912A61Q45356732-D2F52C4A-AEAF-42F5-968D-2B49622A54A2Q46300761-5A6DCE81-BA66-4362-889F-98492589AE00
P2860
Use of Vaxfectin adjuvant with DNA vaccine encoding the measles virus hemagglutinin and fusion proteins protects juvenile and infant rhesus macaques against measles virus
description
2008 nî lūn-bûn
@nan
2008 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Use of Vaxfectin adjuvant with ...... macaques against measles virus
@ast
Use of Vaxfectin adjuvant with ...... macaques against measles virus
@en
Use of Vaxfectin adjuvant with ...... macaques against measles virus
@nl
type
label
Use of Vaxfectin adjuvant with ...... macaques against measles virus
@ast
Use of Vaxfectin adjuvant with ...... macaques against measles virus
@en
Use of Vaxfectin adjuvant with ...... macaques against measles virus
@nl
prefLabel
Use of Vaxfectin adjuvant with ...... macaques against measles virus
@ast
Use of Vaxfectin adjuvant with ...... macaques against measles virus
@en
Use of Vaxfectin adjuvant with ...... macaques against measles virus
@nl
P2093
P2860
P921
P356
P1476
Use of Vaxfectin adjuvant with ...... macaques against measles virus
@en
P2093
Adrián Vilalta
Alain Rolland
Chien-Hsiung Pan
Fernando P Polack
Gretchen S Jimenez
Robert J Adams
P2860
P304
P356
10.1128/CVI.00120-08
P407
P577
2008-08-01T00:00:00Z